¼¿ï´ëÇб³º´¿ø International Symposium of Transplantation 2019 : 2019-12-06±³À°ÀÏÀÚ : 2019-12-06
±³À°Àå¼Ò : ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø
±³À°ÁÖÁ¦ :
International Symposium of Transplantation 2019ÁÖÃÖ±â°ü : ¼¿ï´ëÇб³º´¿ø
´ã´çÀÚ : ¼¸®¶ó
¿¬¶ôó : 02-2072-3550
À̸ÞÀÏ :
lira123@hanmail.net ±³À°Á¾·ù : ³»°ú, ¿Ü°ú±âŸ
Âü¼®¿¹»óÀοø : 70¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 35ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç 13:30~13:45 Àλ縻, Ãà»ç ¼¿ï´ëÇб³º´¿øÀå ±è¿¬¼ö µî(¼¿ï´ëÇб³º´¿ø µî)
±³À°½Ã°£ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç 13:45~14:00 50 year''s history of kidney transplantation at SNUH ÇÏÁ¾¿ø(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç 14:00~14:40 Current standard of care and controversies in treatment of antibody-mediated rejection Rajil B Mehta(University of Pittsburg)
±³À°½Ã°£ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç 14:40~14:50 Role of Plasmapheresis & IVIG and their adequate dose Á¤º´ÇÏ(¼¿ï¼º¸ðº´¿ø)
Åä·Ð 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç 14:50~15:10 Panel discussion ±è¿µÈÆ µî(¼¿ï¾Æ»êº´¿ø µî)
±³À°½Ã°£ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç 15:10~15:20 Role of Rituximab & Bortezomib and their adequate dose Çã±ÔÇÏ(¼¼ºê¶õ½ºº´¿ø)
Åä·Ð 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç 15:20~15:40 Panel discussion ¹ÚÀç¹ü µî(»ï¼º¼¿ïº´¿ø µî)
ÈÞ½Ä 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç 15:40~16:10 ()
±³À°½Ã°£ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç 16:10~16:40 Preventive and pre-emptive therapy for antibody-mediated rejection Takkaki Kobayashi(Aichi Medical University School of Medicine)
±³À°½Ã°£ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç 16:40~16:50 Striking difficult problems of Antibody mediated rejection at Clinical field ¾çÀç¼®(¼¿ï´ëÇб³º´¿ø)
Åä·Ð 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç 16:50~17:10 Panel discussion ±èÁß°æ(ºÀ»ýº´¿ø µî)
±³À°½Ã°£ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç 17:10~17:30 Insurance regulations of Antibody-mediated rejection treatment À̽Ä(ÀüºÏ´ëÇб³º´¿ø)
Åä·Ð 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç 17:30~17:50 Questions and Discussions ()
±âŸ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°´ç 17:50~18:00 ¸ÎÀ½¸» ÇÏÁ¾¿ø(¼¿ï´ëÇб³º´¿ø)